Medicare launches program for beneficiaries with serious and chronic illnesses
FDA Roundup: Biosimilar Approval, Hereditary Angioedema Treatment Receives Orphan Drug Designation
Check out important updates from the FDA for the week of September 30.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Approves Dupixent as First Biologic Treatment for COPD
Dupixent is a fully human monoclonal antibody that inhibits the signaling of the IL4 and IL13 pathways.
Schizophrenia Drug Approved by FDA Represents First New Treatment Option in Decades
The approval of xanomeline and trospium chloride (Cobenfy) from Bristol Myers Squibb represents a “transformative moment in the treatment of schizophrenia.”
FDA Approves Levacetylleucine for Treatment of Niemann-Pick Disease Type C
The approval comes shortly after the FDA approved arimoclomol from Zevra Therapeutics to treat neurological manifestations of the disease in combination with miglustat.
FDA, CDC: E-Cigarette Use Among Youth Continues to Plummet
Initiatives such as media campaigns and legislative rulings by the agencies have likely contributed to the decline.
